2016 International Congress

Wednesday, June 22, 2016

12:00pm-1:30pm

The effects of gait and balance training on walking economy in early and mid stage Huntington’s disease

J.L. Kubica, J. Szymura, E. Mirek, M. Filip, M. Wiecek, M. Maciejczyk, M. Rudzinska, U. Pustulka-Piwnik, J. Stozek, S. Pasiut (Krakow, Poland)

Huntington's disease  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The efficacy of quantitative ^99mTc-TRODAT-1 SPECT in diagnosis of aged patients with Parkinson’s disease

C.F. Lee, C.Y. Wei, G.U. Huang, I.J. Chen, B. Hsu (Changhua, Taiwan)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The evaluation of metabolic differences by using 18F-FDG-PET/CT in demented and non demented Idiophatic Parkinson’s disease patients

S. Altinayar, M. Bakir, Y. Demirtas, Y. Kaplan (Malatya, Turkey)

Cognitive disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The feasibility of measuring fatigability in early-stage Parkinson’s disease using functional MRI

Y. Xing, N. Bajaj, S.T. Schwarz, D.P. Auer (Nottingham, United Kingdom)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The improvement of a tardive diskinesia movements by inline skating

S.C.B. Casagrande, R.G. Cury, A.C.d.L. Pardini, D.B. Coelho, C.d.O. Souza, T.G. de Oliveira, M.G.d.S. Ghilardi, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The interactive walkway: Towards assessing gait-environment interactions in a clinical setting

D.J. Geerse, M. Roerdink, B. Coolen, J. Marinus, J.J. van Hilten (Leiden, Netherlands)

Phenomenology and clinical assessment of movement disorders  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The International Parkinson and Movement Disorder Society – non-motor rating scale (MDS-NMS): Results from the cognitive pre-testing and phases 1 and 2 of an international validation

K. Ray Chaudhuri, D. Weintraub, A. Schrag, P. Martinez-Martin, On behalf of EUROPAR, The MDS Non-Motor PD Study Group (London, United Kingdom)

Rating scales  ·  Exhibit Hall located in Hall B, Level 2

12:00pm-1:30pm

The movement disorder associated with NMDAR-antibody encephalitis: An expert-rater video study

J.A. Varley, K.P. Bhatia, R.C. Dale, V. Fung, T. Granata, M.A.J. Tijssen, A. Lang, J.P. Lin, M. Lim, T. Lynch, N. Nardocci, K.D. Sethi, S.R. Irani (Oxford, United Kingdom)

Clinical Phenomenology and Rating Scales

12:00pm-1:30pm

The nucleocytoplasmic transport of ataxin-3 as pathogenic mechanism in spinocerebellar ataxia type 3

T. Schmidt, A. Sowa, I.M. Martins, M. Abedi, Z. Wang, J. Schmidt, H. Tricoire, O. Riess (Tübingen, Germany)

Ataxiz, Choreas

12:00pm-1:30pm

The patient’s perspective: The effect of dopamine on Parkinson symptoms

H. Zach, M.F. Dirkx, J.W. Pasman, B.R. Bloem, R.C. Helmich (Vienna, Austria)

Parkinson's disease: Neuroimaging and neurophysiology  ·  Exhibit Hall located in Hall B, Level 2